Compare IMNM & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | ELMD |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 326.9M |
| IPO Year | 2020 | 2010 |
| Metric | IMNM | ELMD |
|---|---|---|
| Price | $21.49 | $27.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $32.80 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 975.9K | 98.7K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.40 | ★ 52.94 |
| EPS | N/A | ★ 1.30 |
| Revenue | $6,941,000.00 | ★ $54,716,000.00 |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | $1,127.34 | $11.51 |
| P/E Ratio | ★ N/A | $21.43 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $11.09 | $23.01 |
| 52 Week High | $30.06 | $47.40 |
| Indicator | IMNM | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 31.21 | 34.64 |
| Support Level | $19.39 | $27.14 |
| Resistance Level | $23.25 | $29.57 |
| Average True Range (ATR) | 1.19 | 0.92 |
| MACD | -0.42 | 0.59 |
| Stochastic Oscillator | 1.42 | 77.17 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.